Use of resting myocardial 18F-FDG imaging in the detection of unstable angina

ObjectiveIncreased myocardial glucose metabolism occurs with the onset of myocardial ischemia and may persist even after the restoration of blood flow, termed as ‘ischemic memory’. Previous studies have demonstrated that 18F-fluorodeoxyglucose (18F-FDG) is a sensitive marker of myocardial ischemia and may have potential utility in diagnosing unstable angina (UA). This study aimed to explore the value of 18F-FDG PET/CT in diagnosing UA. Patients and methodsThirty-four patients (17 male patients; mean age, 59±6 years) with suspected UA were prospectively recruited. Resting myocardial 18F-FDG PET/CT imaging was performed 21±9 h (2–46 h) after the latest onset of angina pectoris. Resting or exercise myocardial perfusion imaging (MPI) and coronary angiography were performed. ‘Focal’ or ‘focal on diffuse’ myocardial 18F-FDG uptake was defined as abnormal, whereas other patterns of myocardial uptake, including ‘focal’ uptake on the basal segments, were considered as normal. The final diagnosis of UA was based on a comprehensive analysis of ECG, MPI, and coronary angiography. ResultsOf the 21 patients with a final diagnosis of UA, 18 had increased 18F-FDG uptake (sensitivity 85.7%), whereas, of the 13 patients without UA, only one had abnormal 18F-FDG uptake (specificity 92.3%). The sensitivity of resting 18F-FDG imaging was higher than that of resting MPI (85.7 vs. 52.4%, P=0.016). Moreover, six UA patients with only exercise-induced ischemia showed abnormal 18F-FDG uptake at rest. ConclusionThis pilot study demonstrated that resting 18F-FDG PET/CT imaging is an accurate and sensitive technique for the identification of UA.

[1]  M. Rohit,et al.  Comparison of Tc-99m tetrofosmin myocardial perfusion scintigraphy and exercise F18-FDG imaging in detection of myocardial ischemia in patients with coronary artery disease , 2015, Journal of Nuclear Cardiology.

[2]  T. Shiga,et al.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  D. Jain,et al.  18F-FDG Cardiac Studies for Identifying Ischemic Memory , 2012, Current Cardiovascular Imaging Reports.

[4]  M. Gonen,et al.  Treadmill Exercise Inducing Mild to Moderate Ischemia Has No Significant Effect on Skeletal Muscle or Cardiac 18F-FDG Uptake and Image Quality on Subsequent Whole-Body PET Scan , 2012, The Journal of Nuclear Medicine.

[5]  F. Wackers Acute chest pain of uncertain etiology, the short and long view , 2012, Journal of Nuclear Cardiology.

[6]  V. Dilsizian Metabolic Imaging for Identifying Antecedent Myocardial Ischemia and Acute Coronary Syndrome in the Emergency Department , 2011, Current cardiology reports.

[7]  V. Dilsizian,et al.  Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial. , 2010, Journal of the American College of Cardiology.

[8]  B. Scirica Acute coronary syndrome: emerging tools for diagnosis and risk assessment. , 2010, Journal of the American College of Cardiology.

[9]  V. Dilsizian 18F-FDG Uptake as a Surrogate Marker for Antecedent Ischemia , 2008, Journal of Nuclear Medicine.

[10]  Diwakar Jain,et al.  Myocardial 18F-FDG Uptake After Exercise-Induced Myocardial Ischemia in Patients with Coronary Artery Disease , 2008, Journal of Nuclear Medicine.

[11]  S. Bergmann,et al.  Diagnostic accuracy of β-methyl-p-[123I]-iodophenyl-pentadecanoic acid (BMIPP) imaging: A meta-analysis , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[12]  A. Lahiri,et al.  The role of cardiovascular imaging techniques in the assessment of patients with acute chest pain , 2007, Nuclear medicine communications.

[13]  Yi-Hwa Liu,et al.  [18F]Fluorodeoxyglucose as a memory marker of transient myocardial ischaemia , 2007, Nuclear medicine communications.

[14]  C. Isasi,et al.  Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET , 2005, Nuclear medicine communications.

[15]  M. Nishimura,et al.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. , 2005, European heart journal.

[16]  Diwakar Jain,et al.  Direct Imaging of Exercise-Induced Myocardial Ischemia With Fluorine-18–Labeled Deoxyglucose and Tc-99m-Sestamibi in Coronary Artery Disease , 2003, Circulation.

[17]  T. Iwase,et al.  The physiological uptake pattern of (18)F-FDG in the left ventricular myocardium of patients without heart disease. , 2000, The journal of medical investigation : JMI.

[18]  G. Shulman,et al.  Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited-duration coronary occlusion. , 2000, Circulation.

[19]  M. Schwaiger,et al.  Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium. , 1989, Journal of the American College of Cardiology.

[20]  T. Spinks,et al.  Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography , 1988, Cardiovascular Drugs and Therapy.

[21]  M E Phelps,et al.  Assessment of regional myocardial ischemia by positron-emission computed tomography. , 1982, American heart journal.

[22]  S. Nakatani,et al.  Assessment of myocardial ischemic memory using speckle tracking echocardiography. , 2012, JACC. Cardiovascular imaging.

[23]  M. Blaufox,et al.  Intra-individual variability of cardiac uptake on serial whole-body F-FDG PET , 2005 .

[24]  R. Gropler,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.